BioNexus Gene Lab Corp. Net Income
BioNexus Gene Lab Corp. (BGLC) reported Net Income of -$286.45 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-14
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$286.45K.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$543.58K.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$1.04M.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$708.99K.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for fiscal 2025 was -$2.98M.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for fiscal 2024 was -$1.60M.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for fiscal 2023 was -$2.63M.
- BioNexus Gene Lab Corp. net income (loss) attributable to parent for fiscal 2022 was -$355.97K, a 147.36% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$286.45K 10-Q · filed 2026-08-14 | -$830.03K 10-Q · filed 2026-08-14 | -$1.87M derived: sum of 3 quarters · filed 2026-08-14 | -$2.58M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$543.58K 10-Q · filed 2026-08-14 | -$1.58M derived: sum of 2 quarters · filed 2026-08-14 | -$2.29M derived: sum of 3 quarters · filed 2026-08-14 | -$2.90M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.75M derived: sum of 2 quarters · filed 2026-04-14 | -$2.36M derived: sum of 3 quarters · filed 2026-08-14 | -$2.98M 10-K · filed 2026-04-14 | |||
| 2025-09-30 | -$708.99K 10-Q · filed 2025-11-14 | -$1.33M derived: sum of 2 quarters · filed 2026-08-14 | -$1.95M 10-Q · filed 2025-11-14 | -$2.30M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$616.17K 10-Q · filed 2026-08-14 | -$1.24M 10-Q · filed 2026-08-14 | -$1.59M derived: sum of 3 quarters · filed 2026-08-14 | -$2.93M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$623.33K 10-Q · filed 2026-08-14 | -$971.65K derived: sum of 2 quarters · filed 2026-08-14 | -$2.32M derived: sum of 3 quarters · filed 2026-08-14 | -$2.12M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2024-12-31 | -$348.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.69M derived: sum of 2 quarters · filed 2026-04-14 | -$1.49M derived: sum of 3 quarters · filed 2026-04-14 | -$1.60M 10-K · filed 2026-04-14 | |||
| 2024-09-30 | -$1.35M 10-Q · filed 2025-11-14 | -$1.15M derived: sum of 2 quarters · filed 2025-11-14 | -$1.25M 10-Q · filed 2025-11-14 | -$941.56K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $199.10K 10-Q · filed 2025-08-18 | $95.35K 10-Q · filed 2025-08-18 | $403.81K derived: sum of 3 quarters · filed 2025-08-18 | -$2.21M derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | -$103.76K 10-Q · filed 2025-05-15 | $204.71K derived: sum of 2 quarters · filed 2025-05-15 | -$2.40M derived: sum of 3 quarters · filed 2025-05-15 | -$2.66M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $308.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$2.30M derived: sum of 2 quarters · filed 2025-04-15 | -$2.56M derived: sum of 3 quarters · filed 2025-04-15 | -$2.63M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | -$2.61M 10-Q · filed 2024-11-15 | -$2.87M derived: sum of 2 quarters · filed 2024-11-15 | -$2.94M 10-Q · filed 2024-11-15 | -$3.09M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | -$259.25K 10-Q · filed 2024-11-15 | -$328.32K 10-Q · filed 2024-08-14 | -$485.29K derived: sum of 3 quarters · filed 2024-11-15 | -$562.69K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-03-31 | -$69.07K 10-Q · filed 2024-11-15 | -$226.03K derived: sum of 2 quarters · filed 2024-11-15 | -$303.44K derived: sum of 3 quarters · filed 2024-11-15 | -$442.10K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2022-12-31 | -$156.97K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$234.37K derived: sum of 2 quarters · filed 2024-04-16 | -$373.03K derived: sum of 3 quarters · filed 2024-04-16 | -$355.97K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$77.40K 10-Q/A · filed 2024-03-26 | -$216.06K derived: sum of 2 quarters · filed 2024-03-26 | -$199.00K 10-Q/A · filed 2024-03-26 | -$109.75K derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2022-06-30 | -$138.66K 10-Q/A · filed 2024-03-26 | -$121.60K 10-Q · filed 2023-08-16 | -$32.35K derived: sum of 3 quarters · filed 2024-03-26 | $262.97K derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2022-03-31 | $17.07K 10-Q/A · filed 2024-03-26 | $106.31K derived: sum of 2 quarters · filed 2024-03-26 | $401.63K derived: sum of 3 quarters · filed 2024-03-26 | $429.89K derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2021-12-31 | $89.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $384.56K derived: sum of 2 quarters · filed 2023-03-31 | $412.83K derived: sum of 3 quarters · filed 2023-03-31 | $751.57K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $295.32K 10-Q · filed 2022-11-14 | $323.58K derived: sum of 2 quarters · filed 2022-11-14 | $662.33K 10-Q · filed 2021-11-15 | $488.17K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $28.26K 10-Q · filed 2022-11-14 | $367.01K 10-Q · filed 2021-08-12 | $192.84K derived: sum of 3 quarters · filed 2022-11-14 | $427.30K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-03-31 | $338.74K 10-Q · filed 2022-11-14 | $164.58K derived: sum of 2 quarters · filed 2022-11-14 | $399.04K derived: sum of 3 quarters · filed 2022-11-14 | $363.20K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2020-12-31 | -$174.16K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $60.30K derived: sum of 2 quarters · filed 2022-04-06 | $24.45K derived: sum of 3 quarters · filed 2022-04-06 | $1.09M 10-K · filed 2022-04-06 | |||
| 2020-09-30 | $234.46K 10-Q · filed 2021-11-15 | -$60.03K 10-Q · filed 2020-11-03 | $198.62K derived: sum of 2 quarters · filed 2021-11-15 | $1.27M 10-Q · filed 2021-11-15 | -$174.53K 10-Q · filed 2020-11-03 | $1.18M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$35.84K 10-Q · filed 2021-08-12 | -$66.54K 10-Q · filed 2020-08-11 | $1.03M 10-Q · filed 2021-08-12 | -$114.49K 10-Q · filed 2020-08-11 | $941.23K derived: sum of 3 quarters · filed 2021-11-15 | $919.20K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-03-31 | $1.07M 10-Q · filed 2021-11-15 | -$47.95K 10-Q · filed 2020-05-08 | $977.07K derived: sum of 2 quarters · filed 2021-11-15 | $955.04K derived: sum of 3 quarters · filed 2021-11-15 | $884.64K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2019-12-31 | -$92.58K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | -$114.61K derived: sum of 2 quarters · filed 2021-03-30 | -$185.00K derived: sum of 3 quarters · filed 2021-03-30 | -$246.47K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$22.03K 10-Q/A · filed 2020-11-09 | -$92.43K derived: sum of 2 quarters · filed 2020-11-09 | -$153.89K 10-Q/A · filed 2020-11-09 | -$216.87K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$70.40K 10-Q · filed 2020-08-11 | -$131.87K 10-Q · filed 2020-08-11 | -$194.84K derived: sum of 3 quarters · filed 2020-08-11 | -$283.80K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$61.47K 10-Q · filed 2020-05-08 | -$124.44K derived: sum of 2 quarters · filed 2020-05-08 | -$213.40K derived: sum of 3 quarters · filed 2020-05-08 | -$252.87K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | -$62.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$151.94K derived: sum of 2 quarters · filed 2020-03-31 | -$191.41K derived: sum of 3 quarters · filed 2020-03-31 | $26.45K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | -$88.96K 10-Q · filed 2019-11-14 | -$128.43K derived: sum of 2 quarters · filed 2019-11-14 | $89.43K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | -$39.47K 10-Q · filed 2019-08-09 | $178.39K 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | $271.86K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |